AIMS: To examine whether test utilization and prevalence of ischemia with positron emission tomography (PET) myocardial perfusion imaging (MPI) follow the previously described trends with single photon computed tomography (SPECT). METHODS AND RESULTS: MPI studies performed between January 2003 and December 2017 were identified. Number of PET and SPECT MPI studies performed per year was determined. Trends in the proportion of studies showing any ischaemia (>0%) with both modalities were compared before and after adjusting for baseline differences in patient characteristics using propensity scores. Interaction between imaging modality and year of testing was examined using modified Poisson regression. A total of 156 244 MPI studies were performed (30% PET and 70% SPECT). Between 2003 and 2017, the number of PET studies increased from 18 to 61 studies/1000 patient encounters, while SPECT volumes declined from 169 to 34/1000 patient encounters (P < 0.001 for within-group comparisons). The prevalence of any ischaemia in SPECT-tested patients declined from 53.9% to 28.3% between 2003 and 2017, whereas ischaemia prevalence in PET-tested patients declined from 57.2% to 38.2% (P < 0.001 for within-modality comparisons), with more PET studies showing ischaemia compared to SPECT [relative risk (RR) 1.44, 95% confidence interval (CI) 1.42-1.47; P < 0.001]. After propensity score matching of 26 066 patients tested with SPECT with 26 066 patients tested with PET, the between-modality difference in ischaemia prevalence was significantly attenuated, with a slightly higher overall likelihood of detecting ischaemia with PET compared to SPECT (RR 1.08, 95% CI 1.05-1.11; P < 0.001). CONCLUSIONS: Utilization of PET MPI at a large-volume referral centre increased significantly between 2003 and 2017. Despite a significant decrease in the prevalence of ischaemia with SPECT and PET during the same period, the decline was less with PET, perhaps related to baseline risk of tested patients. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To examine whether test utilization and prevalence of ischemia with positron emission tomography (PET) myocardial perfusion imaging (MPI) follow the previously described trends with single photon computed tomography (SPECT). METHODS AND RESULTS: MPI studies performed between January 2003 and December 2017 were identified. Number of PET and SPECT MPI studies performed per year was determined. Trends in the proportion of studies showing any ischaemia (>0%) with both modalities were compared before and after adjusting for baseline differences in patient characteristics using propensity scores. Interaction between imaging modality and year of testing was examined using modified Poisson regression. A total of 156 244 MPI studies were performed (30% PET and 70% SPECT). Between 2003 and 2017, the number of PET studies increased from 18 to 61 studies/1000 patient encounters, while SPECT volumes declined from 169 to 34/1000 patient encounters (P < 0.001 for within-group comparisons). The prevalence of any ischaemia in SPECT-tested patients declined from 53.9% to 28.3% between 2003 and 2017, whereas ischaemia prevalence in PET-tested patients declined from 57.2% to 38.2% (P < 0.001 for within-modality comparisons), with more PET studies showing ischaemia compared to SPECT [relative risk (RR) 1.44, 95% confidence interval (CI) 1.42-1.47; P < 0.001]. After propensity score matching of 26 066 patients tested with SPECT with 26 066 patients tested with PET, the between-modality difference in ischaemia prevalence was significantly attenuated, with a slightly higher overall likelihood of detecting ischaemia with PET compared to SPECT (RR 1.08, 95% CI 1.05-1.11; P < 0.001). CONCLUSIONS: Utilization of PET MPI at a large-volume referral centre increased significantly between 2003 and 2017. Despite a significant decrease in the prevalence of ischaemia with SPECT and PET during the same period, the decline was less with PET, perhaps related to baseline risk of tested patients. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Rory Hachamovitch; Benjamin Nutter; Mark A Hlatky; Leslee J Shaw; Michael L Ridner; Sharmila Dorbala; Rob S B Beanlands; Benjamin J W Chow; Elizabeth Branscomb; Panithaya Chareonthaitawee; W Guy Weigold; Szilard Voros; Suhny Abbara; Tsunehiro Yasuda; Jill E Jacobs; John Lesser; Daniel S Berman; Louise E J Thomson; Subha Raman; Gary V Heller; Adam Schussheim; Richard Brunken; Kim A Williams; Susan Farkas; Dominique Delbeke; Uwe J Schoepf; Nathaniel Reichek; Stuart Rabinowitz; Steven R Sigman; Randall Patterson; Carolyn R Corn; Richard White; Ella Kazerooni; James Corbett; Sabahat Bokhari; Josef Machac; Erminia Guarneri; Salvador Borges-Neto; John W Millstine; James Caldwell; James Arrighi; Udo Hoffmann; Matthew Budoff; Joao Lima; James R Johnson; Barbara Johnson; Mariya Gaber; Julie A Williams; Courtney Foster; Jon Hainer; Marcelo F Di Carli Journal: J Am Coll Cardiol Date: 2012-01-31 Impact factor: 24.094
Authors: Manesh R Patel; Steven R Bailey; Robert O Bonow; Charles E Chambers; Paul S Chan; Gregory J Dehmer; Ajay J Kirtane; L Samuel Wann; R Parker Ward Journal: J Am Coll Cardiol Date: 2012-05-09 Impact factor: 24.094
Authors: W Lane Duvall; Mridula Rai; Alan W Ahlberg; David M O'Sullivan; Milena J Henzlova Journal: J Nucl Cardiol Date: 2015-02-05 Impact factor: 5.952
Authors: Vasken Dilsizian; Stephen L Bacharach; Rob S Beanlands; Steven R Bergmann; Dominique Delbeke; Sharmila Dorbala; Robert J Gropler; Juhani Knuuti; Heinrich R Schelbert; Mark I Travin Journal: J Nucl Cardiol Date: 2016-07-08 Impact factor: 5.952
Authors: Albert Flotats; Juhani Knuuti; Matthias Gutberlet; Claudio Marcassa; Frank M Bengel; Philippe A Kaufmann; Michael R Rees; Birger Hesse Journal: Eur J Nucl Med Mol Imaging Date: 2011-01 Impact factor: 9.236
Authors: Islam Y Elgendy; Ahmed Mahmoud; Jonathan J Shuster; Rami Doukky; David E Winchester Journal: J Nucl Cardiol Date: 2015-08-08 Impact factor: 5.952
Authors: Hein J Verberne; Wanda Acampa; Constantinos Anagnostopoulos; Jim Ballinger; Frank Bengel; Pieter De Bondt; Ronny R Buechel; Alberto Cuocolo; Berthe L F van Eck-Smit; Albert Flotats; Marcus Hacker; Cecilia Hindorf; Philip A Kaufmann; Oliver Lindner; Michael Ljungberg; Markus Lonsdale; Alain Manrique; David Minarik; Arthur J H A Scholte; Riemer H J A Slart; Elin Trägårdh; Tim C de Wit; Birger Hesse Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-21 Impact factor: 9.236
Authors: Krishna K Patel; Femina S Patel; Timothy M Bateman; Kevin F Kennedy; Poghni A Peri-Okonny; A Iain McGhie; Brett W Sperry; Leslee Shaw; Marcelo Di Carli; Randall C Thompson; Ibrahim M Saeed; Philip G Jones; John A Spertus Journal: Circ Cardiovasc Imaging Date: 2022-02-15 Impact factor: 7.792
Authors: Roel S Driessen; Pepijn A van Diemen; Pieter G Raijmakers; Juhani Knuuti; Teemu Maaniitty; S Richard Underwood; Eike Nagel; Lourens F H J Robbers; Ahmet Demirkiran; Martin B von Bartheld; Peter M van de Ven; Leonard Hofstra; G Aernout Somsen; Igor I Tulevski; Ronald Boellaard; Albert C van Rossum; Ibrahim Danad; Paul Knaapen Journal: Eur Heart J Date: 2022-09-01 Impact factor: 35.855